Literature DB >> 25420723

Interventions combining motivational interviewing and cognitive behaviour to promote medication adherence: a literature review.

Sandra L Spoelstra1, Monica Schueller, Melissa Hilton, Kimberly Ridenour.   

Abstract

AIMS AND
OBJECTIVES: This article presents an integrative review of the evidence for combined motivational interviewing and cognitive behavioural interventions that promote medication adherence. We undertook this review to establish a scientific foundation for development of interventions to promote medication adherence and to guide clinical practice.
BACKGROUND: The World Health Organization has designated medication adherence as a global problem. Motivational interviewing and cognitive behaviour interventions have been found to individually promote medication adherence. However, there is a gap in the literature on the effect of combined motivational interviewing and cognitive behavioural approaches to promote medication adherence.
DESIGN: Integrative review.
METHODS: COCHRANE, PubMed and CINAHL were searched to access relevant studies between 2004-2014. Inclusion criteria were interventions combining motivational interviewing and cognitive behavioural therapy with medication adherence as the outcome. Articles were assessed for measures of adherence and methodological rigour. Analysis was performed using an integrative review process.
RESULTS: Six articles met the inclusion criteria. A randomised controlled trial reported pretreatment missed doses of 5·58 and post-treatment of 0·92 and trended towards significance. Four cohort studies had effect sizes of 0·19-0·35 (p < 0·05). A case study had a pretreatment adherence rate of 25% and post-treatment 77% (p < 0·01).
CONCLUSIONS: Although there were a limited number of studies on combined motivational interviewing and cognitive behavioural interventions, five out of six were effective at improving medication adherence. Future studies with large rigorous randomised trials are needed. RELEVANCE TO CLINICAL PRACTICE: This review provides clinicians with the state of the science in relation to combined motivational interviewing and cognitive behavioural therapy interventions that promote medication adherence. A summary of intervention components and talking points are provided to aid nurses in informing decision-making and translating evidence into practice.
© 2014 John Wiley & Sons Ltd.

Keywords:  cognitive behavioural therapy; integrative review; intervention; medication adherence; motivational interviewing

Mesh:

Year:  2014        PMID: 25420723     DOI: 10.1111/jocn.12738

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  4 in total

Review 1.  Opioid Treatment of Migraine: Risk Factors and Behavioral Issues.

Authors:  Melissa T Stone; Valerie Weed; Ronald J Kulich
Journal:  Curr Pain Headache Rep       Date:  2016-09

2.  Site-Randomized Controlled Trial of a Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression Among Youth Living With HIV in the United States.

Authors:  Larry K Brown; Miriam Chernoff; Betsy D Kennard; Graham J Emslie; Kathryn Lypen; Sarah Buisson; Adriana Weinberg; Laura B Whiteley; Shirley Traite; Chelsea Krotje; Lauren Harriff; Ellen Townley; Amber Bunch; Murli Purswani; Ray Shaw; Stephen A Spector; Allison Agwu; David E Shapiro
Journal:  J Acquir Immune Defic Syndr       Date:  2021-12-15       Impact factor: 3.771

Review 3.  Effectiveness of healthcare educational and behavioral interventions to improve gout outcomes: a systematic review and meta-analysis.

Authors:  Karishma Ramsubeik; Laurie Ann Ramrattan; Gurjit S Kaeley; Jasvinder A Singh
Journal:  Ther Adv Musculoskelet Dis       Date:  2018-11-19       Impact factor: 5.346

Review 4.  Effectiveness of Interventions to Promote Medication Adherence in Schizophrenic Populations in Thailand: A Systematic Review.

Authors:  Suchanart Inwanna; Cherdsak Duangchan; Alicia K Matthews
Journal:  Int J Environ Res Public Health       Date:  2022-03-02       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.